International group of experts develops an evidence-based clinical practice guideline (algorithm) for using metformin to prevent/treat antipsychotic-induced weight gain.
Health Canada has reviewed evidence on the link between glucagon-like peptide-1 (GLP-1) receptor agonists and suicide, self-harm and suicidal/self-harm ideation.